15 results
PRE 14A
PHAT
Phathom Pharmaceuticals Inc
31 Mar 23
Preliminary proxy
4:06pm
and Nasdaq. Our board of directors has determined that Ms. Kunz is an “audit committee financial expert” as defined by applicable SEC rules and has … it provide any expert assurance or professional certification regarding the company’s financial statements. The audit committee relies, without
DEF 14A
7e38ygc1 eodcizegkr
8 Apr 20
Definitive proxy
8:31am
424B4
gi8l1xf qkog
28 Oct 19
Prospectus supplement with pricing info
12:00am
S-1/A
bdk njvsaw
15 Oct 19
IPO registration (amended)
6:39am
S-1
EX-10.11
1d7h 5ahucjs4jwy
30 Sep 19
IPO registration
12:00am
S-1
4xe4raihvcqf
30 Sep 19
IPO registration
12:00am
DRS/A
1c3 nspd1lu
30 Aug 19
Draft registration statement (amended)
12:00am
DRS
m8a0i2zzicrbld bn
26 Jul 19
Draft registration statement
12:00am
- Prev
- 1
- Next